WHO ICTRP trial
Augmenting response to entecavir using a temporary peginterferon alpha-2a add-on…
NL-OMON39757 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON39757 |
|---|---|
| Public title | Augmenting response to entecavir using a temporary peginterferon alpha-2a add-on strategy for the treatment of HBeAg-positive chronic hepatitis B (ARES study) - Long-term follow-up of a peginterferon alpha-2a add-on strategy in chronic hepatitis B patients treated with entecavir |
| Scientific title | Augmenting response to entecavir using a temporary peginterferon alpha-2a add-on strategy for the treatment of HBeAg-positive chronic hepatitis B (ARES study) - Long-term follow-up of a peginterferon alpha-2a add-on strategy in chronic hepatitis B patients treated with entecavir - ARES LTFU |
| Primary sponsor | Stichting Leveronderzoek |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 4 |
| Countries | China;Poland;Romania;Turkey |
| Conditions | Chronic hepatitis B;10019654;10047438;Chronic hepatitis B |
| Interventions | A temporary peginterferon alpha-2a add-on strategy during entecavir therapy for 24 weeks ;chronic hepatitis B;entecavir;peginterferon;sustained response |
| Registration date | Feb 26, 2014 |
| Target size | 20 |
| Secondary IDs | 2008-006239-11;NCT00877760;NL26630.078.09 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: